152 related articles for article (PubMed ID: 6172088)
1. Amylase in fallopian tube and serous ovarian neoplasms: immunohistochemical localization.
Bruns DE; Mills SE; Savory J
Arch Pathol Lab Med; 1982 Jan; 106(1):17-20. PubMed ID: 6172088
[TBL] [Abstract][Full Text] [Related]
2. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of amylase in common epithelial tumors of the ovary.
Ueda G; Yamasaki M; Inoue M; Tanaka Y; Abe Y; Ogawa M
Int J Gynecol Pathol; 1985; 4(3):240-4. PubMed ID: 2414239
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia.
Kalir T; Wang BY; Goldfischer M; Haber RS; Reder I; Demopoulos R; Cohen CJ; Burstein DE
Cancer; 2002 Feb; 94(4):1078-82. PubMed ID: 11920478
[TBL] [Abstract][Full Text] [Related]
6. Expression of Fas and FasL in human serous ovarian epithelial tumors.
van Haaften-Day C; Russell P; Davies S; King NJ; Tattersall MH
Hum Pathol; 2003 Jan; 34(1):74-9. PubMed ID: 12605369
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic challenge of secondary (metastatic) ovarian tumors simulating primary endometrioid and mucinous neoplasms.
Hart WR
Pathol Int; 2005 May; 55(5):231-43. PubMed ID: 15871720
[TBL] [Abstract][Full Text] [Related]
8. A comparative immunohistochemical study on amylase localization in the rat and human exocrine pancreas.
Aughsteen AA
Saudi Med J; 2001 May; 22(5):410-5. PubMed ID: 11376382
[TBL] [Abstract][Full Text] [Related]
9. Amylase in human lungs and the female genital tract. Histochemical and immunohistochemical localization.
Hayashi Y; Fukayama M; Koike M; Nakayama T
Histochemistry; 1986; 85(6):491-6. PubMed ID: 2430919
[TBL] [Abstract][Full Text] [Related]
10. Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts.
Woo MM; Gilks CB; Verhage HG; Longacre TA; Leung PC; Auersperg N
Gynecol Oncol; 2004 May; 93(2):315-9. PubMed ID: 15099939
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of lysozyme in primary ovarian tumors using the immunoperoxidase technique.
Cazzola P; Lo Re V; Matturri L; Tedeschi D
Basic Appl Histochem; 1984; 28(2):169-76. PubMed ID: 6383334
[TBL] [Abstract][Full Text] [Related]
12. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.
Huang LW; Garrett AP; Bell DA; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2000 Jun; 77(3):369-76. PubMed ID: 10831344
[TBL] [Abstract][Full Text] [Related]
14. Amylase-producing ovarian neoplasm with pseudo-Meigs' syndrome and elevated pleural fluid amylase: case report and ultrastructure.
Cramer SF; Bruns DE
Cancer; 1979 Nov; 44(5):1715-21. PubMed ID: 498043
[TBL] [Abstract][Full Text] [Related]
15. [Differential diagnosis of borderline serous and mucinous ovarian tumors].
Bolkvadze MP; Gabuniia UA; Sheĭnina LI
Arkh Patol; 1981; 43(2):21-6. PubMed ID: 6261721
[TBL] [Abstract][Full Text] [Related]
16. [Determination of amylase and lipase in peritoneal fluid: diagnostic value in ovarian cysts (author's transl)].
Esmatjes Mompó E; Bruix Tudó J; Rodamilans Pérez M; Navarro Colás S
Med Clin (Barc); 1981 Jul; 77(3):121-3. PubMed ID: 6168874
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.
Loy TS; Calaluce RD; Keeney GL
Mod Pathol; 1996 Nov; 9(11):1040-4. PubMed ID: 8933513
[TBL] [Abstract][Full Text] [Related]
18. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
[TBL] [Abstract][Full Text] [Related]
19. [A case of amylase-producing ovarian tumor].
Tanaka Y; Ueda G; Tanizawa O; Miyake H; Kohno M; Nishiyama S; Inoue H; Ikeuchi H; Sekigawa S; Matsunaga S
Gan No Rinsho; 1986 Jan; 32(1):111-6. PubMed ID: 2419596
[TBL] [Abstract][Full Text] [Related]
20. Serous ovarian neoplastic amylase (SONA): a potentially useful marker for serous ovarian tumors.
Van Kley H; Cramer S; Bruns DE
Cancer; 1981 Sep; 48(6):1444-9. PubMed ID: 6168366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
